companies massachusetts-general-hospital 
IP Law 360
OCTOBER 3, 2022
A Delaware federal judge has rebuffed a biotechnology company's bid for a new trial after a jury determined it owed a rival and Massachusetts General Hospital $4.7 million for infringing their genetic testing patents, while agreeing with some of the plaintiffs' requests to boost their award.
IP Law 360
AUGUST 27, 2021
A Delaware federal jury on Friday found that European genetic testing company Qiagen willfully infringed a pair of patents owned by Massachusetts General Hospital and biotech company ArcherDX, awarding royalties and lost profits totaling about $4.7
43(B)log
JANUARY 21, 2022
Thirty-eight of the 43 authors who undertook the study are affiliated with Massachusetts General Hospital and the remaining five authors are Guardant personnel. Guardant bases its contentions that Reveal works on “[p]eer reviewed data published by Parikh, et al., in the journal of Cancer Research.”
Expert insights. Personalized for you.
40 
Let's personalize your content